1. Australia Stocks

  2. •

    Technology services

  3. •

    Information technology services
PharmX Technologies Limited

PharmX Technologies Limited

AASX:PHX
0.07
AUD
+0.00
(+2.86%)
0.00EPS
55.66MMarket Cap
Feb 25Next Earn
PharmX Technologies Limited
ASX:PHX
(Australian Securities Exchange)

Recent

price

0.07

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
AUD
0.09
0.08
0.08
0.08
0.07
0.07
0.06
0.05
0.04
0.04
0.03
0.02
0.02
0.01
0.01
0.01
Revenue per Share
- -
0.01
0.02
0.02
0.02
0.02
- -
-0.02
- -
-0.02
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
0.01
0.01
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.01
0.02
0.04
0.06
0.07
0.07
0.07
0.05
0.05
0.04
0.03
0.04
0.04
0.04
0.03
0.03
Book Value per Share
-0.03
-0.02
- -
0.02
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.01
- -
0.01
0.01
0.01
Tangible Book Value per Share
255
255
255
258
266
269
270
270
270
270
364
543
597
597
598
599
Basic Weighted Avg Shares
22
21
21
20
19
18
16
14
11
10
9
13
12
6
6
7
Sales/Revenue/Turnover
8.01
12.81
29.87
25.97
16.82
14.92
9.32
4.76
-6.62
-5.28
-14.62
-7.2
2.85
-12.86
-21.01
-19.44
Operating Margin (%)
1
1
- -
- -
- -
- -
- -
- -
- -
- -
1
2
2
1
1
1
Depreciation Expense
1
2
6
6
4
5
- -
-6
- -
-4
- -
1
- -
-1
-2
- -
Net Income, GAAP
- -
- -
- -
- -
3.96
- -
99
- -
61.38
- -
61.57
19.72
93.96
- -
52.74
434.18
Effective Tax Rate (%)
5.18
8.31
28.84
31.34
22.63
25.87
0.17
-43.51
2.25
-41.49
1.93
8.59
2.11
-17.46
-27.27
-3.61
Profit Margin (%)
-14
-14
- -
5
8
8
7
7
11
4
4
4
3
10
4
4
Working Capital
6
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
LT Debt
3
5
11
16
19
20
20
14
14
10
13
23
23
22
16
16
Total Equity
15.94
24.12
52.29
38.96
17.24
- -
0.07
- -
-2.03
- -
-8.98
-3.95
0.09
- -
-3.35
28.79
Return on Invested Capital (%)
17.77
21.9
61.77
47.01
24.26
- -
0.14
- -
1.78
- -
1.63
6.46
1.1
- -
-9.09
-2.23
Return on Capital (%)
45.81
46.41
78.68
47.01
24.26
23.86
0.14
-34.69
1.78
-34.68
1.52
6.04
1.09
-4.63
-9.27
-1.66
Return on Common Equity (%)

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.63%
8.46%
-0.28%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
-2,404.07%
-18.17%
-85.08%
Sales/Revenue/Turnover
-5.86%
0.86%
12.84%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
6
2024
- -
- -
6
2025
- -
- -
7

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Similar Companies
Credo Technology Group Holding Ltd (NASDAQ:CRDO)
International Business Machines Corporation (NYSE:IBM)
Tata Consultancy Services Limited (NSE:TCS)
Infosys Limited (NSE:INFY)
HCL Technologies Limited (NSE:HCLTECH)
Cloudflare, Inc. (NYSE:NET)
Business
PharmX Technologies Limited operates as a health technology and software provider focusing on the Australian and New Zealand pharmacy sector. The company develops and delivers integrated digital solutions including pharmacy management software, electronic ordering gateways, supplier marketplaces, and data analytics services to improve ordering accuracy, operational efficiency, and market visibility for pharmacies and suppliers. Headquartered in Sydney, Australia, PharmX was founded in 1950 and serves customers across Australia and neighboring markets, with a portfolio that spans Gateway for B2B pharmacy-supplier connectivity, Marketplace for product promotion and procurement, and Analytics for supplier performance and pharmacy operations insights. The business primarily targets independent and chain pharmacies, wholesalers, and suppliers, offering products and services designed to streamline point-of-sale, dispensing, invoicing, and supply chain workflows. Recent developments include the expansion of the supplier ecosystem through the introduction of a dedicated Supplier Portal, enhancements to real-time analytics, and ongoing network growth to broaden market access and trading efficiency. Subsidiaries and corporate reorganizations support a unified Health Services segment that emphasizes software-as-a-service and hardware-enabled solutions for the pharmacy channel. The group emphasizes regional expansion within Australia and New Zealand, maintaining local support and implementation capabilities to service regulatory and operational requirements. PharmX operates under the brand and product suite focused on The Gateway, Marketplace, and Data & Analytics offerings, with ongoing initiatives to integrate suppliers, optimize trade flows, and deliver data-driven decision support to pharmacy customers. The company maintains a public profile on the Australian Securities Exchange under the PHX.AX ticker, reflecting ongoing reporting and corporate governance standards.